Tuesday, May 18, 2021

Sanofi-GSK COVID vax shows strong immune responses in Phase 2 trial

A COVID-19 vaccine developed by pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) has shown strong rates of neutralising antibody responses against the infectious Coronavirus disease in the Phase-II trial.

from Zee News :Zee News - Health https://ift.tt/3hyEotX
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Lumpy Skin Disease: Animal Infection Spreading Rapidly In India- Do We Need To Be Worried?

These days, a disease is spreading rapidly among animals in many states of India. The name of this disease is Lumpy Skin Disease. This disea...